Acrivon Therapeutics, Inc. Common Stock (ACRV) vs CareCloud, Inc. (CCLD)
A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and CareCloud, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACRV
Acrivon Therapeutics, Inc. Common Stock
$1.98HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CCLD
CareCloud, Inc.
$2.04HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ACRV vs CCLD
growth of $100 · dividends reinvested · last 4yACRV -88.1% (-41.3%/yr)CCLD -35.0% (-10.2%/yr)CCLD compounded faster over this window
Log scale — wide-divergence pair
ACRV CCLD
ACRV vs CCLD: by the numbers
- •CCLD is the larger company ($87M vs $85M market cap).
- •CCLD is profitable (6.21% net margin) while ACRV runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ACRV | CCLD |
|---|---|---|
| P/E ratio | N/A | 29.23 |
| Forward P/E | N/A | 7.42 |
| P/S ratio | N/A | 0.67 |
| P/B ratio | 0.98 | 4.98 |
| EV / EBITDA | N/A | 4.63 |
| FCF yield | N/A | 25.00% |
Profitability
| Metric | ACRV | CCLD |
|---|---|---|
| Gross margin | 0.00% | 46.51% |
| Operating margin | 0.00% | 7.31% |
| Net margin | 0.00% | 6.21% |
| ROE | -85.65% | 45.93% |
| ROIC | -88.28% | 12.79% |
Growth (annualized)
| Metric | ACRV | CCLD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 0.18% |
| Total return CAGR (5Y) | N/A | -23.18% |
Frequently asked
- Is ACRV or CCLD more profitable?
- CCLD runs the higher net margin — ACRV at 0.00% versus CCLD at 6.21%.
Go deeper
Dig into the metrics
CareCloud P/E ratioAcrivon Therapeutics, Inc. Common Stock ROECareCloud ROEAcrivon Therapeutics, Inc. Common Stock operating marginCareCloud operating marginAcrivon Therapeutics, Inc. Common Stock revenue growthCareCloud revenue growthAcrivon Therapeutics, Inc. Common Stock free cash flowCareCloud free cash flow
Acrivon Therapeutics, Inc. Common Stock & CareCloud appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.